With Current R&D Model Reaching Its Limit, Industry Going Digital to Boost Efficiency: Astellas Chairman

Astellas Pharma Chairman Yoshihiko Hatanaka The pharmaceutical industry is working to leverage the advancement of digital technologies and personalized and preemptive medicine to streamline drug development amid snowballing R&D costs, Astellas Pharma Chairman Yoshihiko Hatanaka tells Jiho. “The current business...read more